Old Web
English
Sign In
Acemap
>
authorDetail
>
Sumitra Thongprasert
Sumitra Thongprasert
Bangkok Hospital
Medicine
Oncology
Internal medicine
Afatinib
Pathology
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study
2019
Lung cancer management
Sumitra Thongprasert
Sarayut Lucien Geater
Dana Clement
A. Abdelaziz
Jasmin Reyes-Igama
Dragana Jovanovic
A. Alexandru
Michael Schenker
Virote Sriuranpong
Piotr Serwatowski
Sheethal Suresh
A. Cseh
Rabab Gaafar
Show All
Source
Cite
Save
Citations (4)
157P Second-line afatinib for patients with locally advanced or metastatic NSCLC harbouring common EGFR mutations: A phase IV study
2018
Journal of Thoracic Oncology
Sumitra Thongprasert
Sarayut Lucien Geater
D Clément
A. Abdelaziz
J. Reyer-Igama
Dragana Jovanovic
S. Suresh
Agnieszka Cseh
Rabab Gaafar
Show All
Source
Cite
Save
Citations (0)
ESMO Women for Oncology 2016: a very personal tale of my professional life in Asia
2017
Sumitra Thongprasert
Show All
Source
Cite
Save
Citations (0)
Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC
2016
Journal of Thoracic Oncology
Rafael Rosell
Elia Neninger
Marianne Nicolson
Rudolf M. Huber
Sumitra Thongprasert
Purvish M. Parikh
Erik D'Hondt
Show All
Source
Cite
Save
Citations (8)
1